热淋清颗粒联合甲磺酸左氧氟沙星治疗泌尿系感染患者的临床效果观察
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Clinical efficacy of Relinqing granule combined with levofloxacin mesylate in the treatment of urinary tract infection
  • 作者:鲁晓蓓
  • 英文作者:LU Xiao-bei;Pharmaceutical Department,731 Hospital of China Aerospace Science and Industry Group;
  • 关键词:热淋清颗粒 ; 甲磺酸左氧氟沙星 ; 泌尿系感染 ; 临床观察
  • 英文关键词:Relinqing granules;;Levofloxacin mesylate;;Urinary infection;;Clinical observation
  • 中文刊名:PLHY
  • 英文刊名:Chinese Journal of Clinical Rational Drug Use
  • 机构:中国航天科工集团七三一医院药剂科;
  • 出版日期:2019-03-20
  • 出版单位:临床合理用药杂志
  • 年:2019
  • 期:v.12
  • 语种:中文;
  • 页:PLHY201908007
  • 页数:2
  • CN:08
  • ISSN:13-1389/R
  • 分类号:22-23
摘要
目的观察甲磺酸左氧氟沙星联合热淋清颗粒治疗泌尿系感染患者的临床效果。方法选取医院泌尿外科收治的患者72例,随机分为观察组和对照组,每组36例。观察组给予左氧氟沙星和热淋清颗粒治疗,对照组单用左氧氟沙星治疗。观察比较2组治疗总有效率,记录2组尿频、尿急、尿痛改善时间。结果观察组痊愈率为58. 33%、总有效率为91. 67%,高于对照组的27. 78%、61. 11%(P <0. 01);观察组尿频、尿急、尿痛改善时间均短于对照组(P <0. 05)。结论左氧氟沙星联合热淋清颗粒治疗泌尿系感染患者比单用甲磺酸左氧氟沙星疗效显著,不良反应少,安全可靠,值得临床推广应用。
        Objective To observe the clinical effect of levofloxacin mesylate combined with Relinqing granule in the treatment of urinary tract infection. Methods Seventy-two patients with urinary tract infection were randomly divided into observation group and control group,36 cases in each group. The observation group was treated with levofloxacin and Relinqing granules,while the control group was treated with levofloxacin alone. The total effective rate of the two groups was observed and compared. The improvement time of frequency of urination,urgency of urine and pain of urine in the two groups was recorded. Results The cure rate and total effective rate of the observation group were 58. 33% and 91. 67%,higher than27. 78% and 61. 11% of the control group( P < 0. 01). The improvement time of frequency,urgency and pain in the observation group was shorter than that in the control group( P < 0. 05). Conclusion Levofloxacin combined with Relinqing Granule is more effective than levofloxacin mesylate alone in the treatment of urinary tract infections,with fewer adverse reactions,safety and reliability,which is worthy of clinical application.
引文
[1]Foxman B.Epidemiology of urinary tract infections:incidence,morbidity,and economic costs[J].American Journal of Medicine,2003,49(2):53-70.
    [2]王燕芬,赵玉芬.泌尿系感染抗菌治疗的药学监护[J].安徽医学,2012,33(12):1609-1611.
    [3]陈以平.肾脏病的辩证与辩病治疗[M].北京:人民卫生出版社,2003:304-329.
    [4]Fisher JF.Candida urinary tract infections-epidemiology,pathogenesis,diagnosis and treatment:executive summary[J].Clin Infect Dis2011,52:S429-32.
    [5]Negri M,Silva S,Henriques M,et al.Candida tropicalis biofilms:artificial urine urinary catheters,and flow model[J].Med Mycol,2011,49:739-747.
    [6]吴爱玲.热淋清颗粒治疗尿路感染临床分析[J].中国药物经济学,2012,7(6):180-181.
    [7]洪义芬,陈文,范平云,等.热淋清胶囊联合阿奇霉素治疗尿路感染的临床研究[J].现代药物与临床,2017,32(9):1742-1745.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700